Robert J Gould

Director, Fulcrum Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.5M

Companies

Latest trade

Feb 2, 2026

Companies

Fulcrum Therapeutics, Inc.Director −$0.5M

Trades

FULC Sold 15,000 shares at $10.72 · planned $0.2M Feb 2

FULC Sold 15,000 shares at $11.87 · planned $0.2M Jan 2

FULC Sold 15,000 shares at $11.03 · planned $0.2M Nov 19

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.